GLP-1 medications like Ozempic and Wegovy are everywhere right now, and for women with PMOS, the appeal is understandable — insulin resistance sits at the centre of so many PMOS cases, and these drugs were built to target exactly that. But "promising results in a trial" and "right for you long-term" are two very different things. Here's what the evidence actually shows. The risks worth knowing about: Digestive side effects are common and can be significant — nausea, vomiting,
